CAPLIPOINT2023-07-012023-09-30 CAPLIPOINT2023-07-012023-09-30 CAPLIPOINT2023-07-012023-09-30in-bse-fin:OneOperatingExpenses01Member CAPLIPOINT2023-07-012023-09-30in-bse-fin:FourOperatingExpenses01Member CAPLIPOINT2023-09-30 iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 524742 CAPLIPOINT NOTLISTED Caplin Point Laboratories Limited Equity 2023-04-01 2024-03-31 2023-11-09 2023-11-01 INR Crores Half yearly 11:00:00 12:30:00 2023-11-09 2023-11-09 true Cash Flow Indirect Not applicable Single segment Pharmaceutical Formualtions 2023-07-01 2023-09-30 Unaudited Standalone 1792200000.00 244870000.00 2037070000.00 458440000.00 199680000.00 -93700000.00 90970000.00 210000.00 67240000.00 242280000.00 965120000.00 1071950000.00 0.00 1071950000.00 270900000.00 -19900000.00 251000000.00 0.00 820950000.00 0.00 0.00 0.00 0.00 820950000.00 1400000.00 822350000.00 0.00 0.00 151900000.00 2 10.82 10.76 0.00 0.00 10.82 10.76 0.00 0.00 0.00 Standalone Notes 1) The Unaudited Standalone results for three months and half year ended September 30, 2023 were reviewed and recommended by the Audit Committee and approved by the Board of Directors at their respective meetings held on 9th November, 2023 and have been subjected to Limited Review by the Statutory Auditors of the Company. An unqualified opinion has been issued by them thereon. 2) The Unaudited Standalone financial results of the Company have been prepared in accordance with the Indian Accounting Standards prescribed under Section 133 of the Companies Act, 2013 ( the Act ) read with relevant rules issued thereunder ( Ind AS ) and other accounting principles generally accepted in India and in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. 3) The Company is engaged in the sole activity of carrying on the business of Pharmaceutical Formulations and therefore, has only one reportable segment in accordance with Ind AS 108 Operating Segments . Hence no separate segment reporting is applicable to the Company. 4) Other Income and Profits Before Tax for the Quarter and Half year ended Sep 30,2023 includes Dividend of Rs. 15.29 Crs and 19.45 Cr respectively as against Rs. 7.75 Cr for the Quarter and 30.66 Crs for Half year ended Sep 30, 2022, received from our wholly owned subsidiary Caplin Point Far East Limited, Hong Kong. 5) During the Quarter ended and Half Year ended 30th September, 2023 the Company has allotted 7,000 and 38,000 equity shares of Rs. 2/- each under the Employees Stock Option Schemes respectively and the total number of equity shares of the Company stands at 7,59,40,746. The Company had allotted Nil and 11,666 shares during the Quarter and Half year ended 30th September 2022 respectively. 6) Previous periods' figures have been regrouped / reclassified to be in conformity with current period's classification/disclosure, wherever necessary. For and on behalf of the Board Dr. Sridhar Ganesan Managing Director Place: Chennai Date: 9th Nov,2023 Single segment 2023-04-01 2023-09-30 Unaudited Standalone 3528800000.00 517600000.00 4046400000.00 885180000.00 408130000.00 -91630000.00 188200000.00 500000.00 133900000.00 478200000.00 2002480000.00 2043920000.00 0.00 2043920000.00 489900000.00 -29700000.00 460200000.00 0.00 1583720000.00 0.00 0.00 0.00 0.00 1583720000.00 1400000.00 1585120000.00 0.00 0.00 151900000.00 2 20.86 20.75 0.00 0.00 20.86 20.75 0.00 0.00 0.00 Other Expenses 242280000.00 Other Expenses 478200000.00 1524500000.00 356730000.00 0.00 0.00 33690000.00 0.00 0.00 0.00 3335400000.00 0.00 2145000000.00 27200000.00 5507600000.00 0.00 112900000.00 7535420000.00 569900000.00 1214880000.00 2283600000.00 696400000.00 1365300000.00 0.00 365500000.00 5925680000.00 0.00 239700000.00 6735280000.00 0.00 0.00 14270700000.00 151900000.00 12507100000.00 12659000000.00 12659000000.00 0.00 0.00 4300000.00 4300000.00 0.00 112200000.00 0.00 129300000.00 245800000.00 0.00 783700000.00 416300000.00 1200000000.00 165700000.00 200000.00 1365900000.00 0.00 0.00 1611700000.00 14270700000.00 500000.00 -54600000.00 -1401210000.00 0.00 -13830000.00 0.00 0.00 -195000000.00 0.00 -272200000.00 0.00 0.00 0.00 133900000.00 0.00 0.00 0.00 0.00 0.00 -11900000.00 194500000.00 245600000.00 11000000.00 -4700000.00 0.00 0.00 -11900000.00 1600000.00 0.00 -2258440000.00 -214520000.00 0.00 0.00 0.00 364600000.00 0.00 -579120000.00 0.00 40000000.00 0.00 158700000.00 0.00 0.00 0.00 0.00 0.00 135200000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 585000000.00 0.00 0.00 0.00 194500000.00 340800000.00 0.00 581200000.00 0.00 197600000.00 0.00 0.00 100000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 151900000.00 500000.00 0.00 0.00 -152300000.00 -533820000.00 10000000.00 -523820000.00 1220200000.00 696380000.00 1800000.00 1800000.00 400000.00 400000.00 0.00 0.00